Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5–11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad051Source: DataRank Database

Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5–11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022 is a research paper published in The Journal of Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.26)OA: hybridTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Allan W. Taylor ORCID,Lara J. Akinbami ORCID,Andrea Thames-Allen,Anna R Yousaf ORCID,Angela P. Campbell ORCID

Live enrichment

PubMed:36821777 PMC:PMC10563003 OpenAlex:https://openalex.org/W4321606984

Centers for Disease Control and Prevention

Grant: 200-2012-53661

Centers for Disease Control and Prevention

Grant: 200-2012-50430-0005

Intramural CDC HHS

Grant: CC999999

FWCI

2.26

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: public-domain

journalhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiad051/49596736/jiad051.pdf

publisherhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiad051/49596736/jiad051.pdf

publisherhttps://academic.oup.com/jid/article-pdf/228/2/143/50880656/jiad051.pdf

journalhttps://doi.org/10.1093/infdis/jiad051

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36821777

Fields of Study

Kawasaki Disease and Coronary ComplicationsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 VaccinesChildHumansCOVID-19BNT162 VaccineSARS-CoV-2Systemic Inflammatory Response Syndromepediatric multisystem inflammatory disease, COVID-19 related

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesBNT162 VaccineChildHumansSystemic Inflammatory Response Syndrome

Keywords

MedicineVaccinationPediatricsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusComplication2019-20 coronavirus outbreakImmunologyVirologyDiseaseOutbreakInternal medicineInfectious disease (medical specialty)Covid-19Sars-cov-2Covid-19 VaccineMultisystem Inflammatory Syndrome In ChildrenMis-c

Sustainable Development Goals

SDG 0: Good health and well-being

Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5–11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022

FAIR Checklist

Authors (22)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)